Arax Advisory Partners’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$18.3K	Buy	3,620 +2,220	+159%	+$11.2K	﹤0.01%	1693
2025 Q1	$7.41K	Buy	1,400 +1,120	+400%	+$5.93K	﹤0.01%	1649
2024 Q4	$1.89K	Buy	280 +251	+866%	+$1.7K	﹤0.01%	2023
2024 Q3	$192	Sell	29 -326	-92%	-$2.16K	﹤0.01%	2516
2024 Q2	$2.66K	Buy	+355	New	+$2.66K	﹤0.01%	1862